Closed-loop insulin delivery systems, also known as artificial pancreas systems, combine an insulin pump with a continuous glucose monitor to form a feedback loop. These systems automatically adjust insulin delivery based on real-time blood glucose levels, reducing the burden of diabetes management and improving overall glycemic control.
Medtronic’s MiniMed 780G and Tandem’s Control-IQ are typical representatives of such systems, paving the way for more automated and precise diabetes management.